Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation

髓系抗原呈递细胞微环境维持抗肿瘤T细胞,并通过CD28共刺激促进PD-1阻断。

阅读:2
作者:Jaikumar Duraiswamy,Riccardo Turrini,Aspram Minasyan,David Barras,Isaac Crespo,Alizée J Grimm,Julia Casado,Raphael Genolet,Fabrizio Benedetti,Alexandre Wicky,Kalliopi Ioannidou,Wilson Castro,Christopher Neal,Amandine Moriot,Stéphanie Renaud-Tissot,Victor Anstett,Noémie Fahr,Janos L Tanyi,Monika A Eiva,Connor A Jacobson,Kathleen T Montone,Marie Christine Wulff Westergaard,Inge Marie Svane,Lana E Kandalaft,Mauro Delorenzi,Peter K Sorger,Anniina Färkkilä,Olivier Michielin,Vincent Zoete,Santiago J Carmona,Periklis G Foukas,Daniel J Powell Jr,Sylvie Rusakiewicz,Marie-Agnès Doucey,Denarda Dangaj Laniti,George Coukos

Abstract

The mechanisms regulating exhaustion of tumor-infiltrating lymphocytes (TIL) and responsiveness to PD-1 blockade remain partly unknown. In human ovarian cancer, we show that tumor-specific CD8+ TIL accumulate in tumor islets, where they engage antigen and upregulate PD-1, which restrains their functions. Intraepithelial PD-1+CD8+ TIL can be, however, polyfunctional. PD-1+ TIL indeed exhibit a continuum of exhaustion states, with variable levels of CD28 costimulation, which is provided by antigen-presenting cells (APC) in intraepithelial tumor myeloid niches. CD28 costimulation is associated with improved effector fitness of exhausted CD8+ TIL and is required for their activation upon PD-1 blockade, which also requires tumor myeloid APC. Exhausted TIL lacking proper CD28 costimulation in situ fail to respond to PD-1 blockade, and their response may be rescued by local CTLA-4 blockade and tumor APC stimulation via CD40L.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。